Clinical trials: Enterovirus 71 Infection
- Condition Enterovirus 71 Infection
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Hand, Foot, and Mouth Disease (HFMD), Enterovirus 71 Infection
Bridging Clinical Trial of EV71 Vaccine in Vietnamese Children
The purpose of this study is to evaluate the immunogenicity and safety of an inactivated Enterovirus Type 71 (EV71) vaccine, manufactured by Sinovac, in healthy Vietnamese children aged 6 to 71 months.
- Trial name
- NCT07793175
- Testing
- EV71 vaccine
- Where
- Vietnam
- Volunteers
- 320 people, healthy volunteers welcome
- Sponsor
- Sinovac Biotech Co., Ltd
Enterovirus 71 Infection
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of an EV71 Vaccine
Subjects will receive the first IM injection of study vaccine on Day 1 and will receive a second dose 56 days later. A booster vaccine will be given 365 days after the first dose in subjects 2 months to < 2 years of age.
- Trial name
- NCT03865238
- Testing
- EV71vac
- Where
- 6 sites in Taiwan, Vietnam
- Volunteers
- 3,061 people, healthy volunteers welcome
- Sponsor
- Medigen Vaccine Biologics Corp.